Drug database
Academia developing medicines for rare diseases to receive free EMA scientific advice
To further encourage the development of treatments for rare diseases, EMA will waive all fees for scientific advice for academia developing orphan medicines.
For more information about scientific advice for academia see the EMA website.
More about the EMA’s expert advice.
June 6, 2020
Department of Clinical Trials on Pharmaceuticals